The effect of 50% oxygen on PtCO2 in patients with stable COPD, bronchiectasis, and neuromuscular disease or kyphoscoliosis: randomised cross-over trials.

Janine PilcherDarmiga ThayabaranStefan EbmeierMathew WilliamsGeraldine BackHamish CollieMichael RichardsSusan BibbyRuth SempriniMark WeatherallRichard Beasley

Published in: BMC pulmonary medicine (2020)

Australian New Zealand Clinical Trials Registry ACTRN12615000970549 Registered 16/9/15, ACTRN12615000971538 Registered 16/9/15 and ACTRN12615001056583 Registered 7/10/15.

Keyphrases

clinical trial
chronic obstructive pulmonary disease
open label
cystic fibrosis
double blind
lung function
study protocol
phase ii